Epigenetic modifications in colorectal cancer: Molecular insights and therapeutic challenges

被引:92
|
作者
Vaiopoulos, Aristeidis G. [1 ]
Athanasoula, Kalliopi Ch. [1 ]
Papavassiliou, Athanasios G. [1 ]
机构
[1] Univ Athens, Dept Biol Chem, Sch Med, Athens 11527, Greece
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2014年 / 1842卷 / 07期
关键词
Colorectal cancer; Epigenetics; Histone modification; DNA methylation; Therapy; Prognosis; GLOBAL HISTONE MODIFICATION; TUMOR-SUPPRESSOR GENES; COLON-CANCER; PHASE-I; DNA METHYLATION; DOWN-REGULATION; BETA-CATENIN; E-CADHERIN; COMBINATION; CELLS;
D O I
10.1016/j.bbadis.2014.02.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Colorectal cancer, a leading cause of mortality worldwide, is a multistep disorder that results from the alteration of genetic and epigenetic mechanisms under contextual influence. Epigenetic aberrations, including DNA methylation, histone modifications, chromatin remodeling and non-coding RNAs, affect every aspect of tumor development from initiation to metastasis. Cancer stem cell promotion is also included in the wide spectrum of epigenetic dysregulations. Elucidation of this complex crosstalk network may offer new insights in the molecular interactions involved in the pathogenesis of colorectal carcinogenesis. In the era of translational medicine new horizons are opened for the pursuit of personalized therapeutic approaches and the development of novel and accurate diagnostic, prognostic and therapy-assessment markers. This review discusses the implications of epigenetic mechanisms in tumor biology and their applications "from bench to bedside". (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:971 / 980
页数:10
相关论文
共 50 条
  • [31] Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges
    Shankar, Eswar
    Kanwal, Rajnee
    Candamo, Mario
    Gupta, Sanjay
    SEMINARS IN CANCER BIOLOGY, 2016, 40-41 : 82 - 99
  • [32] DNA methylation and histone modifications as epigenetic regulation in prostate cancer (Review)
    Nowacka-Zawisza, Maria
    Wisnik, Ewelina
    ONCOLOGY REPORTS, 2017, 38 (05) : 2587 - 2596
  • [33] Epigenetic cancer therapy: Proof of concept and remaining challenges
    Mund, Cora
    Lyko, Frank
    BIOESSAYS, 2010, 32 (11) : 949 - 957
  • [34] Advances in epigenetic modifications and cervical cancer research
    Liu, Hui
    Ma, Huimin
    Li, Yang
    Zhao, Hua
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (03):
  • [35] Epigenetic drift towards histone modifications regulates CAV1 gene expression in colon cancer
    Deb, Moonmoon
    Sengupta, Dipta
    Kar, Swayamsiddha
    Rath, Sandip Kumar
    Roy, Subhendu
    Das, Goutam
    Patra, Samir Kumar
    GENE, 2016, 581 (01) : 75 - 84
  • [36] Lung cancer and epigenetic modifications
    Yuce, Gulbahar Darilmaz
    Ersoy, Ebru Ortac
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2016, 64 (02): : 163 - 170
  • [37] Cellular Epigenetic Targets and Epidrugs in Breast Cancer Therapy: Mechanisms, Challenges, and Future Perspectives
    Alalhareth, Ibrahim S.
    Alyami, Saleh M.
    Alshareef, Ali H.
    Ajeibi, Ahmed O.
    Al Munjem, Manea F.
    Elfifi, Ahmad A.
    Alsharif, Meshal M.
    Alzahrani, Seham A.
    Alqaad, Mohammed A.
    Bakir, Marwa B.
    Abdel-Wahab, Basel A.
    PHARMACEUTICALS, 2025, 18 (02)
  • [38] Gut microbiota and epigenetics in colorectal cancer: implications for carcinogenesis and therapeutic intervention
    Pandey, Monu
    Bhattacharyya, Jayanta
    EPIGENOMICS, 2024, 16 (06) : 403 - 418
  • [39] The role of epigenetic therapies in colorectal cancer
    Baretti, Marina
    Azad, Nilofer Saba
    CURRENT PROBLEMS IN CANCER, 2018, 42 (06) : 530 - 547
  • [40] CRC-EBD: Epigenetic Biomarker Database for Colorectal Cancer
    Liu, Xingyun
    Zhang, Xueli
    Chen, Jing
    Ye, Benchen
    Ren, Shumin
    Lin, Yuxin
    Sun, Xiao-Feng
    Zhang, Hong
    Shen, Bairong
    FRONTIERS IN GENETICS, 2020, 11